LCI Lannett Company Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI

Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of Lannett Company, Inc. securities (NYSE: LCI) from September 12, 2013 through November 3, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Lannett investors under the federal securities laws.

To join the Lannett class action, go to http://www.rosenlegal.com/cases-978.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Lannett’s drug pricing relied on unsustainable pricing methodologies; (2) Lannett lacked effective internal controls concerning its drug pricing methodologies; (3) as a result, Lannett’s public statements were materially false and misleading at all relevant times and spurred ongoing investigations by the State of Connecticut Office of the Attorney General and the U.S. Department of Justice. Additionally, media outlets reported that the underlying conduct would likely lead U.S. prosecutors to file criminal charges against Lannett by the end of 2016 for suspected price collusion.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 17, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-978.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

EN
16/11/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lannett Company Inc.

Lannett Company, Inc.: Update following downgrade of CFR to Ca

Our credit view of Lannett reflects unsustainable high debt levels and weak liquidity given expectation for negative EBITDA, partially offset by good pipeline of new products, few years away

Moody's downgrades Lannett's CFR to Ca; outlook stable

Moody's Investors Service ("Moody's") downgraded the ratings of Lannett Company, Inc. ("Lannett"), including the Corporate Family Rating to Ca from Caa1 and the Probability of Default Rating to Ca-PD from B3-PD. Moody's also downgraded the first lien senior secured notes rating to Caa3 from B3. The ...

Lannett Company, Inc.: Update following downgrade to Caa1 CFR

Our credit view of this issuer reflects its high financial leverage.

Moody's announces completion of a periodic review of ratings of Lannet...

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Lannett Company, Inc.. Global Credit Research- 11 Nov 2021. New York, November 11, 2021-- Moody's Investors Service has completed a periodic review of the ratings of Lannett Company, Inc. and other ratings that are associated with the same analytical unit.

Moody's downgrades Lannett's CFR to Caa1; outlook stable

Rating Action: Moody's downgrades Lannett's CFR to Caa1; outlook stable. Global Credit Research- 08 Nov 2021. New York, November 08, 2021-- Moody's Investors Service downgraded the ratings of Lannett Company, Inc., including the Corporate Family Rating to Caa1 from B3 and affirmed the Probability of Default Rating at B3-PD.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch